Therapy for Spondyloarthritis The Role of Extra-articular Manifestations (Eye, Skin)

被引：5

作者：

Carron, Philippe ^{[1
]}

Van Praet, Liesbet ^{[1
]}

Jacques, Peggy ^{[1
]}

Elewaut, Dirk ^{[1
]}

Van den Bosch, Filip ^{[1
]}

机构：

[1] Ghent Univ Hosp, Dept Rheumatol, B-9000 Ghent, Belgium

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2012年 / 38卷 / 03期

关键词：

Therapy; Spondyloarthritis; Extra-articular manifestations; Psoriasis; Uveitis; INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; ACTIVE ANKYLOSING-SPONDYLITIS; INTERMITTENT SHORT COURSES; NECROSIS-FACTOR BLOCKERS; PLAQUE-TYPE PSORIASIS; DOUBLE-BLIND; ANTERIOR UVEITIS; CYCLOSPORINE NEORAL(R); IMPROVES PSORIASIS; CLINICAL-FEATURES;

D O I：

10.1016/j.rdc.2012.08.017

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Spondyloarthritis can be considered one of the prototypes (besides rheumatoid arthritis) of an inflammatory rheumatic disease. The locomotor system is prominently involved with arthritis, enthesitis, dactylitis, sacroiliitis, and/or axial disease; but besides the rheumatologic component, other body systems are frequently affected. Extra-articular manifestations are all the medical conditions and symptoms that are not directly related to the locomotor system. Besides inflammatory bowel diseases, the major concept-related extra-articular manifestations are located in the eye (acute anterior uveitis) and the skin (psoriasis). This review focuses on the possible implications of these nonrheumatologic manifestations regarding the treatment of spondyloarthritis.

引用

页码：583 / +

页数：19

共 89 条

[1]

DRUGS IN EXACERBATION OF PSORIASIS [J].

ABEL, EA ;

DICICCO, LM ;

ORENBERG, EK ;

FRAKI, JE ;

FARBER, EM .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 15 (05) :1007-1022

[2]

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial [J].

Antoni, C ;

Krueger, GG ;

de Vlam, K ;

Birbara, C ;

Beutler, A ;

Guzzo, C ;

Zhou, B ;

Dooley, LT ;

Kavanaugh, A .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1150-1157

[3]

BANARES AA, 1995, J RHEUMATOL, V22, P1112

[4]

Baraliakos X, 2011, ARTHRITIS RHEUM-US, V63, pS972

[5]

BENCHETRIT E, 1986, CUTIS, V38, P45

[6]

Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis [J].

Benitez-Del-Castillo, JM ;

Garcia-Sanchez, J ;

Iradier, T ;

Bañares, A .

EYE, 2000, 14 (3) :340-343

[7]

BerthJones J, 1997, BRIT J DERMATOL, V136, P527, DOI 10.1046/j.1365-2133.1997.d01-1229.x

[8]

Bittencourt MG, 2012, DEV OPHTHALMOL, V51, P134, DOI 10.1159/000336338

[9]

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept [J].

Braun, J ;

Baraliakos, X ;

Listing, J ;

Sieper, J .

ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2447-2451

[10]

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor α agents [J].

Braun, J. ;

Baraliakos, X. ;

Listing, J. ;

Davis, J. ;

Van der Heijde, D. ;

Haibel, H. ;

Rudwaleit, M. ;

Sieper, J. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (04) :639-647

← 1 2 3 4 5 6 7 8 9 →